Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day

NCT: NCT06436924 · COMPLETED

NCT IDNCT06436924
StatusCOMPLETED
Start Date2024-05-14
Completion2026-03-19
SponsorHeart Rhythm Clinical and Research Solutions, LLC (OTHER)
First posted
Last updated

Brief Summary

SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atrial appendage occlusion (LAAO) device implant procedures in a single calendar day.

Frequently Asked Questions

What is Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day?

Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day is a clinical trial registered under NCT06436924. Current status: COMPLETED.

What is the status of NCT06436924?

The current status of NCT06436924 (Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day) is: COMPLETED.

When did Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day start?

Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day started on 2024-05-14.

Related Devices

K190884TigerPaw Pro Left Atrial Appendage Occlusion Fastener And Delivery ToolDatascope Corp.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑